Serum pentraxin 3 in systemic lupus erythematosus: A potential indicator of cutaneous disease activity.

Sahar A IsmailSara Mohamed AwadRania M GamalMarwa A GaberSafaa M HusseinNevin Hammam

Published in: Lupus (2023)

Our results reinforce the important role of Pentraxin3 in SLE patients with skin manifestations, and it may be considered an interesting biomarker for the pattern and extent of cutaneous involvement in SLE.

Keyphrases

disease activity
systemic lupus erythematosus
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
soft tissue
wound healing
human health
risk assessment
climate change